119 related articles for article (PubMed ID: 5138790)
21. Current drug therapy: cardiac glycosides.
Am J Hosp Pharm; 1978 Dec; 35(12):1495-507. PubMed ID: 362913
[TBL] [Abstract][Full Text] [Related]
22. [Clinical pharmacology of cardiac glycosides].
Haustein KO
Pol Tyg Lek; 1978 May; 33(20):817-20. PubMed ID: 673918
[No Abstract] [Full Text] [Related]
23. [Contribution to the quantitative and qual-itative study on the glycoside proscillaridin].
Wülfing von der Heyden D
Med Welt; 1969 Mar; 13():738-43. PubMed ID: 5784356
[No Abstract] [Full Text] [Related]
24. [Use of sirenid in the treatment of circulatory insufficiency in patients with cardiac fibrillation].
Adamova NS
Vrach Delo; 1965 Sep; 9():130-2. PubMed ID: 5871465
[No Abstract] [Full Text] [Related]
25. [CLINICAL EXPERIENCES WITH TALUSIN].
GEBHARDT W; REINDELL H; HEINING J; BUECHNER C; DANNER D; MOSER F; WOEHLER F; HOFFMANN G; WINCKELMANN G
Med Klin; 1965 May; 60():893-8. PubMed ID: 14311922
[No Abstract] [Full Text] [Related]
26. [Therapeutic note on the use of talusin and theo-talusin in ambulatory patients].
Wirthner H
Praxis; 1969 Oct; 58(42):1350-1. PubMed ID: 5396158
[No Abstract] [Full Text] [Related]
27. [On the clinical action of a new derivative of maritime squill (proscillaridinA)].
De Benedetti F; Rizzo F
Minerva Med; 1967 Dec; 58(96):4267-76. PubMed ID: 6083288
[No Abstract] [Full Text] [Related]
28. Drug control of cardiac arrhythmias during anaesthesia.
Payne JP
Ann R Coll Surg Engl; 1970 Mar; 46(3):143-4. PubMed ID: 5445659
[No Abstract] [Full Text] [Related]
29. [CLINICAL EXPERIENCES WITH TALUSIN. 2].
GEBHARDT W; DANNER D; MOSER F; REINDELL H; HEINING J; BUECHNER C; WOEHLER F; HOFFMAN G; WINCKELMANN G
Med Klin; 1965 Jun; 60():964-9. PubMed ID: 14304966
[No Abstract] [Full Text] [Related]
30. [Resorption of alpha-acetyldigoxin and beta-acetyldigoxin studied by ECG].
Watzke K; Klepzig H
Med Klin; 1972 Mar; 67(12):413-7. PubMed ID: 5022885
[No Abstract] [Full Text] [Related]
31. [ON CARDIAC THERAPY WITH TALUSIN: WITH SPECIAL REFERENCE TO CHRONIC COR PULMONALE].
BOPP KP
Munch Med Wochenschr; 1964 Dec; 106():2265-7. PubMed ID: 14343363
[No Abstract] [Full Text] [Related]
32. [Clinical experience with the new cardiac glycoside peruvosid].
Pfund WD
Hippokrates; 1969 Aug; 40(16):646-53. PubMed ID: 5810178
[No Abstract] [Full Text] [Related]
33. [Interaction of drugs used in cardiac insufficiency and heart arrhythmias (problem of the antagonism and synergism of drugs)].
Moĭseev SG
Kardiologiia; 1973 Dec; 13(12):126-9. PubMed ID: 4778830
[No Abstract] [Full Text] [Related]
34. [Clinical experimentation of a new tonicardiac agent: proscillaridine A].
Warembourg H; Carre A
Lille Med; 1970 Mar; 15(3 Suppl 2):447-51. PubMed ID: 5421806
[No Abstract] [Full Text] [Related]
35. [Studies on the relationships between the glycoside dosage effect and pulse frequency behavior].
Döring D; Wenzel V
Z Gesamte Inn Med; 1966 Jun; 21(12):Suppl:137-8. PubMed ID: 5987624
[No Abstract] [Full Text] [Related]
36. [Indications and principle contraindications for cardiotonic agents].
Carlier J; Lisin N
Rev Med Liege; 1976 Sep; 31(17):505-7. PubMed ID: 981849
[No Abstract] [Full Text] [Related]
37. [Clinical observations on a new cardiotonic drug (Talusin)].
Amoroso A; Ghiara F
Minerva Med; 1966 Oct; 57(81):3301-4. PubMed ID: 5955198
[No Abstract] [Full Text] [Related]
38. [Proscillardin A in the treatment of cardiocirculatory insufficiency. Clinco-experimental contribution].
Bellomo A; Strobbia R; Lalloni R; Dalzotto U
Minerva Med; 1967 Dec; 58(96):4246-62. PubMed ID: 6083286
[No Abstract] [Full Text] [Related]
39. [Calcium metabolism in the myocardium and the effect of cardiotonic drugs (review of the literature)].
Gorchakova NA
Vrach Delo; 1980 May; (5):1-5. PubMed ID: 7395151
[No Abstract] [Full Text] [Related]
40. [Heart infarct--course and prognosis].
Bruck A
Z Allgemeinmed; 1969 Oct; 45(28):1312-8. PubMed ID: 5386118
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
